Recombinant STAB1 (Bexmarilimab Biosimilar) antibody
Quick Overview for Recombinant STAB1 (Bexmarilimab Biosimilar) antibody (ABIN7581690)
Target
Antibody Type
Reactivity
Host
Clonality
Conjugate
Application
-
-
Expression System
- CHO Cells
-
Purpose
- Anti-STAB1 Reference Antibody (bexmarilimab)
-
Sequence
- QVTLKESGPT LVKPTQTLTL TCSFSGFSLS TSGMGIGWIR QPPGKALEWL AHIWWDDDKR YNPALKSRLT ISKDTSKNQV VLTMTNMDPV DTATYYCARH YGYDPYYAMD YWGQGTLVTV SSASTKGPSV FPLAPCSRST SESTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ SSGLYSLSSV VTVPSSSLGT KTYTCNVDHK PSNTKVDKRV ESKYGPPCPP CPAPEFEGGP SVFLFPPKPK DTLMISRTPE VTCVVVDVSQ EDPEVQFNWY VDGVEVHNAK TKPREEQFNS TYRVVSVLTV LHQDWLNGKE YKCKVSNKGL PSSIEKTISK AKGQPREPQV YTLPPSQEEM TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS RLTVDKSRWQ EGNVFSCSVM HEALHNHYTQ KSLSLSLGK,EIVLTQSPGT LSLSPGERAT LSCTASSSVS SSYLHWYQQK PGKAPKLLIY RTSNLASGVP SRFSGSGSGT DYTLTISSLQ PEDFATYYCH QYHRSPPTFG QGTKLEIKRT VAAPSVFIFP PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
-
Characteristics
- Anti-STAB1 Reference Antibody (bexmarilimab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
-
Purity
- >95 %
-
Isotype
- IgG4 S228P
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
Therapeutic Agents by Target and Mechanism: STAB1 inhibitors, ADCC, Cytotoxic T lymphocyte stimulator, macrophage stimulator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- 1 mg/mL
-
Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- +4°C,-80°C
-
-
- STAB1 (Bexmarilimab Biosimilar)
-
Target Type
- Biosimilar
-
Molecular Weight
- 145.5 kDa
-
UniProt
- Q9NY15
Target
-